X
XERS icon

Xponance’s Xeris Biopharma Holdings XERS Stock Holding History

Xponance’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
16,457
+2,132
+15% +$13.6K ﹤0.01% 1683
2026
Q1 		$83.1K Buy
14,325
+2,213
+18% +$14.7K ﹤0.01% 1593
2025
Q4 		$95.1K Buy
12,112
+127
+1% +$1K ﹤0.01% 1472
2025
Q3 		$97.6K Buy
11,985
+525
+5% +$3.49K ﹤0.01% 1444
2025
Q2 		$53.5K Buy
11,460
+1,141
+11% +$5.23K ﹤0.01% 1457
2025
Q1 		$56.7K Buy
+10,319
New +$41.7K ﹤0.01% 1386

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Xponance's XERS Position: Q2 2026 in Review

Xponance increased its Xeris Biopharma Holdings (XERS) stake by 15% in Q2 2026, buying an estimated $13.6K and bringing the position to 16,457 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Xponance first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Xponance held 16,457 shares of Xeris Biopharma Holdings worth $130K as of Q2 2026.
  • Xponance bought 2,132 Xeris Biopharma Holdings shares in Q2 2026, an estimated $13.6K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1683 holding.
  • Xponance first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.